Table 1.
Characteristics of study cohorts in included databases.
HEALTHVERITY | Hospital CDM | Open Claims | OPTUM EHR | OPTUM SES | Premier | VA-OMOP | |
---|---|---|---|---|---|---|---|
N | 22,887 | 77,853 | 533,997 | 36,717 | 4,336 | 156,187 | 10,951 |
Age | |||||||
Age < 65 (n [%]) | 9,954 (43.5%) | 44,753 (57.5%) | 256,270 (48.0%) | 22,014 (60.0%) | 1,531 (35.3%) | 81,208 (52.0%) | 3,836 (35.0%) |
Age >= 65 (n [%]) | 12,933 (56.5%) | 33,100 (42.5%) | 277,727 (52.0%) | 14,703 (40.0%) | 2,805 (64.7%) | 74,979 (48.0%) | 7,115 (65.0%) |
Sex | |||||||
Male (n [%]) | 11,769 (51.4%) | 39,911 (51.3%) | 268,957 (50.4%) | 18,495 (50.4%) | 2,354 (54.3%) | 81,155 (52.0%) | 10,225 (93.4%) |
Female (n [%]) | 11,118 (48.6%) | 37,869 (48.6%) | 264,987 (49.6%) | 18,222 (49.6%) | 1,982 (45.7%) | 75,032 (48.0%) | 726 (6.6%) |
Comorbidities | |||||||
Asthma (n [%]) | 1,004 (4.4%) | 5,149 (6.6%) | 82,087 (15.4%) | 4,922 (13.4%) | 628 (14.5%) | 10,497 (6.7%) | 1,153 (10.5%) |
Autoimmune condition (n [%]) | 1,215 (5.3%) | 5,793 (7.4%) | 136,735 (25.6%) | 4,352 (11.9%) | 931 (21.5%) | 6,387 (4.1%) | 3,156 (28.8%) |
Chronic kidney disease (n [%]) | 2,622 (11.5%) | 12,016 (15.4%) | 164,710 (30.8%) | 8,350 (22.7%) | 1,357 (31.3%) | 24,282 (15.5%) | 3,958 (36.1%) |
COPD (n [%]) | 2,213 (9.7%) | 10,153 (13.0%) | 118,421 (22.2%) | 6,777 (18.5%) | 1,066 (24.6%) | 13,699 (8.8%) | 4,641 (42.4%) |
Diabetes (n [%]) | 3,880 (17.0%) | 22,470 (28.9%) | 254,505 (47.7%) | 12,227 (33.3%) | 1,844 (42.5%) | 45,790 (29.3%) | 5,839 (53.3%) |
Heart disease (n [%]) | 5,178 (22.6%) | 22,423 (28.8%) | 319,842 (59.9%) | 17,185 (46.8%) | 2,634 (60.7%) | 47,198 (30.2%) | 7,421 (67.8%) |
Hypertension (n [%]) | 6,410 (28.0%) | 36,071 (46.3%) | 390,171 (73.1%) | 21,290 (58.0%) | 2,977 (68.7%) | 74,311 (47.6%) | 9,087 (83.0%) |
Obesity (n [%]) | 2,238 (9.8%) | 14,878 (19.1%) | 191,071 (35.8%) | 20,188 (55.0%) | 1,626 (37.5%) | 35,462 (22.7%) | 5,677 (51.8%) |